Compugen (CGEN) Tops Q1 EPS by 1c

Compugen (NASDAQ: CGEN) reported Q1 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $513 thousand versus the consensus estimate of $1.48 million.

For earnings history and earnings-related data on Compugen (CGEN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery